Announcements

Job offersmore »

Tweeting Growers

Top 5 - yesterday

Top 5 - last week

Top 5 - last month

Exchange ratesmore »




CAN (QC): Planning underway for new Quebec cannabis project

MYM Nutraceuticals announces that GGS Structures and CannaCanada, subsidiary of MYM, are working together on the planning and design of the 1.5 million sq. ft. Weedon Cannabis Greenhouse Production Project.

Gerry Harrison of GGS Structures commented, "We are thrilled to be working with MYM Nutraceuticals on their project located at Weedon, Quebec. Planning is underway for the first phase of a greenhouse medical cannabis cultivation facility of approximately 100,000 sf. The completed state of the art growing facility will consist of 15 greenhouses that will total 1,500,000 sq. sf."

Weedon Health Canada commercial cannabis production license application has been submitted. MYM's consultants Factotum Consultants, who have successfully obtained Licensed Producer licenses for other clients, are managing the ACMPR application process and have submitted the Weedon application to Health Canada on June 28, 2017.

Weedon quality assurance position filled
David O'Halloran, BSc. has joined the MYM/CanaCanada team as the Quality Assurance Person for the Weedon Project. David O'Halloran brings sixteen years of Quality Assurance and Regulatory Affairs experience to the team. Having graduated from the Cork Institute of Technology in Ireland with a Bachelor of Science in Pharmaceutical Chemistry, David spent five years working in the laboratories of Novartis in the south Coast of Ireland. In 2006, he immigrated to Canada where he began working for PharmAthene Canada Inc., the Canadian division of an American biotech company contracted by the US Department of Defense to develop countermeasures for chemical and biological warfare. Following that he spent two years as Quality Assurance and Regulatory Affairs Director with Vivier Pharma.

David has since been consulting for companies to obtain their licenses from Health Canada, first under the Marihuana for Medical Purposes Regulations (MMPR), and later, the Access to Cannabis for Medical Purposes Regulations (AMPR), submitting applications on behalf of the companies, setting up quality management systems and helping in the design of production facilities to ensure optimal production efficiency and regulatory compliance.

For more information:
MYM Nutraceuticals
1-855-696-2261
info@mymarijuana.ca
www.mymarijuana.ca


GGS Structures
ggs-greenhouse.com

Publication date: 6/30/2017

 


 

Other news in this sector:

9/19/2017 US (NV): First plants are in at Marapharm's Las Vegas facility
9/19/2017 US (MD): University of Maryland cancels MMJ training
9/18/2017 Solution on the horizon for marijuana business banking issues
9/18/2017 "26 percent of Canadians consume cannabis"
9/15/2017 US: Nanoparticle cannabinoid drones to target lung cancer
9/13/2017 US (MI): Medical marijuana shops get temporary reprieve
9/13/2017 Canada: Supreme completes first sales with Aurora Cannabis
9/13/2017 CAN (ON): Tweed Farms to expand three-fold , acquires Garden City Growers
9/13/2017 US: Texas issues first medical marijuana license
9/12/2017 Cannabis Science participates in U.S.-Africa Policy Forum
9/11/2017 US (MA): AmeriCann secures $10,000,000 equity financing commitment
9/11/2017 US: Medical marijuana plants have started to grow in Maryland
9/8/2017 Planning for cannabis odor control in the design phase
9/8/2017 Indoor sunlight now available for medical cannabis growers
9/8/2017 Canada: Ontario to announce MMJ legalization plans today
9/6/2017 Cronos announces MMJ supply agreement in Germany
9/5/2017 US (CA): Future Farm makes progress on Riverside County cultivation facility
9/5/2017 CAN (QC): MYM receives permit approval to begin construction in Laval
9/5/2017 US (CA): "80% of MMJ at conference tested positive for contaminants"
9/5/2017 Israeli company to set up 4 US cannabis factories